Literature DB >> 227566

The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer.

F Nime, J W Pickren, J Vana, B L Aronoff, H W Baker, G P Murphy.   

Abstract

As part of the national survey on the tumorigenesis of oral contraceptive drugs conducted by the American College of Surgeons' Commission on Cancer, a histologic study was made of 94 cases of liver tumors in users and non-users of oral contraceptives. Pathologic criteria were established and then the slides were studied; the results were tabulated to determine the significance of each of the criteria as related to the use of contraceptives. These criteria included tumor size, peliosis hepatis, hemorrhage, necrosis, fibrosis, thrombosis, and vascular alterations of the intima and media. Cases of focal nodular hyperplasia in pill users exhibited greater vascular alterations, fibrosis, peliosis, and tumor size as compared to focal nodular hyperplasia observed in non-pill users. In addition, hemorrhage, necrosis, and peliosis were much more common in hepatic cell adenoma than in focal nodular hyperplasia. In the material reported in this series there were no hepatic cell adenoma cases observed in non-pill users. Focal nodular hyperplasia cases exhibited an overwhelmingly greater degree of vascular intimal and medial alterations than hepatic cell adenoma. The results suggest that the effects of oral contraceptives on the liver may be primarily upon the vasculature.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227566     DOI: 10.1002/1097-0142(197910)44:4<1481::aid-cncr2820440443>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Oestrogen hormone receptors in focal nodular hyperplasia.

Authors:  Manju D Chandrasegaram; Ali Shah; John W Chen; Andrew Ruszkiewicz; David S Astill; Georgina England; Ravish S Raju; Eu Ling Neo; Paul M Dolan; Chuan Ping Tan; Mark Brooke-Smith; Tom Wilson; Robert T A Padbury; Christopher S Worthley
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

Review 2.  Benign solid tumors of the liver: management in the modern era.

Authors:  Georgios Antonios Margonis; Aslam Ejaz; Gaya Spolverato; Neda Rastegar; Robert Anders; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

3.  Laparoscopic liver resection for hepatocellular adenoma.

Authors:  Mohammed Abu Hilal; Francesco Di Fabio; Robert David Wiltshire; Mohammed Hamdan; David M Layfield; Neil William Pearce
Journal:  World J Gastrointest Surg       Date:  2011-07-27

4.  Oral contraceptives and benign tumors of the liver.

Authors:  J G Fitz
Journal:  West J Med       Date:  1984-02

Review 5.  Cyproterone acetate: is it hepato- or genotoxic?

Authors:  T Rabe; K Feldmann; L Heinemann; B Runnebaum
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

6.  Focal nodular hyperplasia of the liver: results of treatment and options in management.

Authors:  J A Pain; A E Gimson; R Williams; E R Howard
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

7.  Malignant epithelioid hemangioendothelioma of the liver, spreading through the hepatic veins.

Authors:  M Fukayama; Z Nihei; T Takizawa; K Kawaguchi; H Harada; M Koike
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

8.  Focal nodular hyperplasia of the liver: a link with sickle cell disease?

Authors:  N D Heaton; J Pain; N C Cowan; J Salisbury; E R Howard
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

9.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.